Bayrak, F. Et Al. 2005. Utility of N-terminal pro-B-type natriuretic peptide to predict clinical outcome in patients with hypertrophic cardiomyopathy. 27th Congress of the European-Society-of-Cardiology , (Stockholm, Sweden), 447.

Bayrak, F., Mutlu, B., Kahveci, G., Eroglu, E., Karaahmet, T., & Basaran, Y., (2005). Utility of N-terminal pro-B-type natriuretic peptide to predict clinical outcome in patients with hypertrophic cardiomyopathy . 27th Congress of the European-Society-of-Cardiology (pp.447). Stockholm, Sweden

Bayrak, Duhan Et Al. "Utility of N-terminal pro-B-type natriuretic peptide to predict clinical outcome in patients with hypertrophic cardiomyopathy," 27th Congress of the European-Society-of-Cardiology, Stockholm, Sweden, 2005

Bayrak, Duhan F. Et Al. "Utility of N-terminal pro-B-type natriuretic peptide to predict clinical outcome in patients with hypertrophic cardiomyopathy." 27th Congress of the European-Society-of-Cardiology , Stockholm, Sweden, pp.447, 2005

Bayrak, F. Et Al. (2005) . "Utility of N-terminal pro-B-type natriuretic peptide to predict clinical outcome in patients with hypertrophic cardiomyopathy." 27th Congress of the European-Society-of-Cardiology , Stockholm, Sweden, p.447.

@conferencepaper{conferencepaper, author={Duhan Fatih BAYRAK Et Al. }, title={Utility of N-terminal pro-B-type natriuretic peptide to predict clinical outcome in patients with hypertrophic cardiomyopathy}, congress name={27th Congress of the European-Society-of-Cardiology}, city={Stockholm}, country={Sweden}, year={2005}, pages={447} }